trial · primary record
Mecobalamin
Thyroid Cancer
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2026-03-12 |
| Primary endpoint | Proportion of patients with HFS grade improvement ≥1 at week 8 |
| Registry ID | NCT07911891 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:55.827Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07911891
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.